Trimethoprim-sulfamethoxazole
Term · Oncology and biomedicine · MLC-T-ONC-008909
An antibiotic drug used to treat infection and prevent pneumocystis carinii pneumonia.
A synthetic combination of two antibacterial agents, trimethoprim and sulfamethoxazole. This synergistic combination, also known as Co-Trimoxazole, inhibits two sequential steps in the bacterial metabolism of folic acid. Trimethoprim is a pyrimidine inhibitor of dihydrofolate reductase; sulfamethoxazole is a sulfamide inhibitor of bacterial dihydrofolate synthase.
| Identifier | MLC-T-ONC-008909 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | SMZ-TMP |
| Synonyms | cotrimoxazole; Eslectin; insozalin; trimedin; trimezole; Bactrimel; Centran; Centrin; Trimethoprim/Sulfamethoxazole |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-008909",
"term": "Trimethoprim-sulfamethoxazole",
"field": "Oncology and biomedicine",
"definitions": [
"An antibiotic drug used to treat infection and prevent pneumocystis carinii pneumonia.",
"A synthetic combination of two antibacterial agents, trimethoprim and sulfamethoxazole. This synergistic combination, also known as Co-Trimoxazole, inhibits two sequential steps in the bacterial metabolism of folic acid. Trimethoprim is a pyrimidine inhibitor of dihydrofolate reductase; sulfamethoxazole is a sulfamide inhibitor of bacterial dihydrofolate synthase."
],
"abbreviation": "SMZ-TMP",
"synonyms": [
"cotrimoxazole",
"Eslectin",
"insozalin",
"trimedin",
"trimezole",
"Bactrimel",
"Centran",
"Centrin",
"Trimethoprim/Sulfamethoxazole"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/trimethoprim-sulfamethoxazole/"
}
Record 16,724 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.